Category Specific RSS

News

Diamonds are a pandemic’s best friend as Michael Hill sales sparkle

Despite the enduring pandemic, lockdowns, restrictions and all the other crap that COVID has rained down upon us (I’m a…

5 years ago

Malaysian Government orders VIP Gloves to shut down all operations

The world could soon have a shortage of disposable gloves with rising COVID cases in Malaysia prompting mass lockdowns, including…

5 years ago

Old trackies are comfy, old work ideas aren’t: how one company is revolutionising digital wellbeing

Pyjama pant clad Zoom meetings are here to stay (I’m wearing spotty ones today, thanks for asking).  The new way…

5 years ago

Forbidden Foods enter lucrative Philippines market ripe for health foods

Home to a population of 110 million with a rapidly growing middle-class, health food company Forbidden Foods (ASX: FFF) has…

5 years ago

It’s not coming home but English soccer fans could soon have beers delivered to their seats

There will be no trophy coming home for English soccer fans but the next best thing for them could be…

5 years ago

AFT Pharmaceuticals gains regulatory approval for new form of pain medication

Fresh off their recent distribution success of their intravenous, non-opioid based pain medication, AFT Pharmaceuticals (ASX: AFP) has ticked another…

5 years ago

World going nuts for Aussie almonds as supply squeeze beckons from California droughts

Readers would know, from the numerous references in my articles, that I’m an oat latte girl. That being said, I…

5 years ago

Youfoodz to cut losses by voting in favour of opportune takeover by HelloFresh

An extraordinary period for shareholders in meal delivery company Youfoodz (ASX: YFZ) is set to come to a close, albeit…

5 years ago

Wesfarmers to enter healthcare with $687m takeover of Priceline

Retail conglomerate Wesfarmers (ASX: WES) is set to create a new health and wellbeing division to service one of Australia’s…

5 years ago

PharmAust partners with the Walter and Eliza Hall Institute to expand COVID-19 research

Forging ahead with their lead drug candidate, PharmAust (ASX: PAA) is expanding on their COVID-19 program. Their new angle is…

5 years ago